Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease

31Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Both CTLA-4-deficient and FoxP3-deficient mice exhibit a short life span due to massive lymphoproliferation (LP) and a systemic autoimmune-like syndrome. Although it has been postulated that both diseases result from regulatory T cell (Treg) defects, there have been no direct complementation studies to elucidate their relationship in homeostatic lymphocyte proliferation during the neonatal period. In this study, reconstitution of sublethally irradiated RAG KO mice with either CTLA-4-deficient or FoxP3-deficient bone marrow (BM) resulted in LP disease similar to that observed in CTLA-4 KO or Scurfy mice, respectively. Although co-injection of BM from wild-type mice inhibited the activation of CTLA-4-deficient or FoxP3-deficient T cells and ameliorated LP disease through extrinsic regulatory mechanisms by Treg cells, mice that had received the BM mixture of Scurfy and CTLA-4 KO BM eventually died of incomplete protection. These results suggest common attributes of both diseases, but expression of both CTLA-4 and FoxP3 on the same cell subset is essential to fully prevent LP disease. © 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Author supplied keywords

Cite

CITATION STYLE

APA

Chikuma, S., & Bluestone, J. A. (2007). Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease. European Journal of Immunology, 37(5), 1285–1289. https://doi.org/10.1002/eji.200737159

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free